Literature DB >> 14962671

Association of variations in monoamine oxidases A and B with Parkinson's disease subgroups.

A Parsian1, B Racette, Z H Zhang, M Rundle, J S Perlmutter.   

Abstract

Idiopathic Parkinson's disease (PD) is an age dependent, neurodegenerative disorder and is predominantly a sporadic disease. A minority of patients has a positive family history for PD and the majority of those families exhibit a complex mode of inheritance. The monoamine oxidases A and B (MAO-A and -B) genes, which are involved in serotonin and dopamine metabolism, are possible candidate genes for susceptibility to PD. Previous association studies of MAO-A and -B in PD have been inconclusive. To determine the role of MAO-A and -B in the development of PD, we screened a sample of 96 patients with familial PD, 164 with sporadic PD, and 180 matched normal controls with dinucleotide repeat markers in these genes. MAO-A and -B gene polymorphisms were strongly associated with total PD (p < 0.00001), familial PD (p < 0.00001), and sporadic PD (p < 0.00001). There were no significant differences between familial or sporadic PD with age of onset younger than 50 years compared to those with age of onset older than 51 years for both MAO-A and -B genes. There was no linkage disequilibrium between these genes in male PD and control groups. The frequency of common haplotypes from MAO-A and -B was different in PD and control group (p = 0.02). Our data indicate that MAO-A and -B may play a role in susceptibility to PD in our sample.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14962671     DOI: 10.1016/j.ygeno.2003.09.002

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  8 in total

1.  The effects of DBH, MAOA, and MAOB on attentional biases for facial expressions.

Authors:  Pingyuan Gong; Shoumin Xi; Guomin Shen; She Li; Peizhe Zhang; Guochang Cao; Fuchang Zhang; Yan Shen; Tiantian Feng; Hua Ma
Journal:  J Mol Neurosci       Date:  2012-10-05       Impact factor: 3.444

2.  A genome-wide linkage screen in the Amish with Parkinson disease points to chromosome 6.

Authors:  Anna C Cummings; Stephen L Lee; Jacob L McCauley; Lan Jiang; Amy Crunk; Lynne L McFarland; Paul J Gallins; Denise Fuzzell; Clare Knebusch; Charles E Jackson; William K Scott; Margaret A Pericak-Vance; Jonathan L Haines
Journal:  Ann Hum Genet       Date:  2011-05       Impact factor: 1.670

3.  Genome-wide linkage screen in familial Parkinson disease identifies loci on chromosomes 3 and 18.

Authors:  Xiaoyi Gao; Eden R Martin; Yutao Liu; Gregory Mayhew; Jeffery M Vance; William K Scott
Journal:  Am J Hum Genet       Date:  2009-03-26       Impact factor: 11.025

4.  Altered platelet monoamine oxidase-B activity in idiopathic Parkinson's disease.

Authors:  Maroof Husain; Rakesh Shukla; Madhu Dikshit; Pradeep K Maheshwari; Devika Nag; Rikhab C Srimal; Prahlad K Seth; Vinay K Khanna
Journal:  Neurochem Res       Date:  2009-03-04       Impact factor: 3.996

5.  Environmental-genetic interactions in the pathogenesis of Parkinson's disease.

Authors:  Yoshio Tsuboi
Journal:  Exp Neurobiol       Date:  2012-09-17       Impact factor: 3.261

6.  Genotator: a disease-agnostic tool for genetic annotation of disease.

Authors:  Dennis P Wall; Rimma Pivovarov; Mark Tong; Jae-Yoon Jung; Vincent A Fusaro; Todd F DeLuca; Peter J Tonellato
Journal:  BMC Med Genomics       Date:  2010-10-29       Impact factor: 3.063

7.  5-(5-Aryl-1,3,4-oxadiazole-2-carbonyl)furan-3-carboxylate and new cyclic C-glycoside analogues from carbohydrate precursors with MAO-B, antimicrobial and antifungal activities.

Authors:  Mohamed Mohamed El-Sadek; Seham Yassen Hassan; Nagwa Said Abd El-Dayem; Galila Ahmed Yacout
Journal:  Molecules       Date:  2012-06-07       Impact factor: 4.411

8.  Polymorphism of the COMT, MAO, DAT, NET and 5-HTT Genes, and Biogenic Amines in Parkinson's Disease.

Authors:  Jolanta Dorszewska; Michal Prendecki; Anna Oczkowska; Agata Rozycka; Margarita Lianeri; Wojciech Kozubski
Journal:  Curr Genomics       Date:  2013-12       Impact factor: 2.236

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.